PapersFlow Research Brief
Peripheral Artery Disease Management
Research Guide
What is Peripheral Artery Disease Management?
Peripheral Artery Disease Management is the clinical application of diagnostic standards, risk factor modification, medical therapies, revascularization techniques, and reporting protocols to treat atherosclerotic narrowing of the peripheral arteries, primarily in the lower extremities, renal, mesenteric, and abdominal aortic regions.
Over 100,000 works address Peripheral Artery Disease Management, establishing standardized guidelines like the 'Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)' by Norgren et al. (2007) with 8051 citations. Key practice guidelines from Hirsch et al. (2006) in Circulation provide evidence-based recommendations for lower extremity, renal, mesenteric, and abdominal aortic PAD, cited 3684 times. Rutherford et al. (1997) set revised standards for reporting lower extremity ischemia outcomes, with 3503 citations.
Research Sub-Topics
Peripheral Artery Disease Guidelines
Develops and updates consensus guidelines for PAD diagnosis, risk stratification, and revascularization strategies. Researchers synthesize evidence from trials to standardize clinical management.
Endovascular Interventions for PAD
Evaluates catheter-based therapies like angioplasty and stenting for lower extremity revascularization. Researchers conduct trials comparing durability, patency rates, and complications.
Antiplatelet Therapy in PAD
Investigates optimal antithrombotic regimens including clopidogrel versus aspirin for PAD-related ischemic events. Researchers analyze trial data on efficacy and bleeding risks.
Epidemiology and Risk Factors of PAD
Conducts global prevalence surveys and identifies risk factors like smoking, diabetes, and dyslipidemia. Researchers model population attributable risks and temporal trends.
Primary Care Detection of PAD
Focuses on ankle-brachial index screening, awareness, and treatment initiation in primary care settings. Researchers study barriers to diagnosis and implementation strategies.
Why It Matters
Peripheral Artery Disease Management reduces amputation risk, myocardial infarction, stroke, and death through structured interventions. Norgren et al. (2007) in 'Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)' outline revascularization strategies for lower extremity PAD, improving walking function and quality of life. Hirsch et al. (2001) showed in primary care that simple ankle-brachial index measurement identifies unrecognized PAD in high-prevalence settings, where atherosclerosis risk factors are common but awareness is low. Recent 2024 ACC/AHA guidelines address four clinical subsets including asymptomatic patients, emphasizing evidence-based diagnosis and treatment to prevent major adverse limb events.
Reading Guide
Where to Start
'Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)' by Norgren et al. (2007), as it provides the foundational inter-society framework for PAD diagnosis, classification, and management across lesion types.
Key Papers Explained
Norgren et al. (2007) 'Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)' builds on Hirsch et al. (2006) 'ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease' by integrating revascularization classifications with comprehensive risk management. Rutherford et al. (1997) 'Recommended standards for reports dealing with lower extremity ischemia: Revised version' supplies the ischemia reporting backbone used in both. Fowkes et al. (2013) 'Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010' contextualizes prevalence for guideline applications.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
The 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease covers four clinical subsets including asymptomatic PAD. An ACC Scientific Statement adds diabetes-specific PAD management. Funding like VentureMed Group's $28M Series C supports PAD device innovation.
Papers at a Glance
In the News
Professor Ellie Tzima receives Leducq Foundation funding ...
This grant will allow us to connect cutting-edge molecular insights with clinical challenges in Peripheral Artery Disease. By understanding how blood vessels fail to respond properly to changes in ...
VentureMed Group Closes $28M Series C Funding to ...
peripheral arterial disease (PAD) and arteriovenous fistulas and grafts (AVF, AVG), today announced the closing of a $28 million Series C financing round led by S3 Ventures, and joined by existing ...
Groundbreaking new centre will turbocharge research and ...
CIRCULIFE aims to help patients with Peripheral Artery Disease (PAD) or Abdominal Aortic Aneurysm (AAA) live longer, healthier lives and will fund a team of researchers, doctors, and patients worki...
Dr. Shipra Arya Awarded American Heart Association Grant
Dr. Shipra Arya has received a $300,000 American Heart Association (AHA) Transformational Project Award to develop an automated method for prognosticating peripheral artery disease (PAD) using deep...
Health Policy Affairs
* On Nov. 7, 2025, SIR, together with the Outpatient Endovascular and Interventional Society (OEIS), American College of Cardiology (ACC), Association of Black Cardiologists (ABC), Society for Card...
Code & Tools
APLUS ML is a simulation framework for conducting usefulness assessments of machine learning models in workflows.
G. Nordestgaard, MD, DMSc
# A Probabilistic Neural Twin for Treatment Planning in Peripheral Pulmonary Artery Stenosis ## Description
## About HemeLB version with improved memory, compilation and scaling ### Resources Readme ### License BSD-3-Clause license Activity ...
MedCodes is a Python package that facilitates the standardization and interpretation of clinical data. ## Drug Classification
Recent Preprints
Management of Lower Extremity Peripheral Artery Disease: Guidelines From the ACC/AHA
Peripheral artery disease (PAD) is a common cardiovascular disease that impacts walking, overall function, and quality of life. It also increases the risk of amputation, myocardial infarction, stro...
Hub - 2024 AHA/ACC/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease
Become a Member # 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/A...
New ACC/AHA Guideline Focused on Management of Lower Extremity PAD - American College of Cardiology
The new *2024 Guideline for the Management of Lower Extremity Peripheral Artery Disease* , released May 14 by the ACC and the American Heart Association (AHA), offers the latest, evidence-based rec...
Peripheral Arterial Disease - StatPearls - NCBI Bookshelf - NIH
## Treatment / Management The treatment and management of PAD focus on alleviating symptoms, preventing disease progression, and reducing major adverse limb events like amputation, cardiovascular m...
ACC Scientific Statement Provides Guidance For ...
A new ACC Scientific Statement on the management of peripheral artery disease (PAD) in adults with diabetes adds context to the 2024 ACC/AHA Lower Extremity PAD Guideline and "emphasizes a modern, ...
Latest Developments
Recent developments in Peripheral Artery Disease (PAD) management research include the release of new 2026 ACC/AHA clinical performance and quality measures for PAD, which provide a comprehensive framework for treatment (ahajournals.org, sciencedirect.com), and updated guidelines from the 2024 ACC/AHA on lower extremity PAD, emphasizing comprehensive care and evidence-based recommendations (ahajournals.org, aafp.org). Additionally, ongoing clinical trials are exploring innovative treatments, including autologous cell therapy, AI-based screening tools, and novel pharmacological approaches (clinicaltrials.ucsf.edu, clinicaltrials.ucsd.edu, clinicaltrials.ucsf.edu).
Sources
Frequently Asked Questions
What are the key guidelines for managing peripheral arterial disease?
Norgren et al. (2007) in 'Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)' provide inter-society consensus on diagnosis, risk reduction, and revascularization for PAD. Hirsch et al. (2006) in 'ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease' cover lower extremity, renal, mesenteric, and abdominal aortic disease management. Ricco et al. (2017) in '2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases' address extracranial carotid, vertebral, mesenteric, renal, upper, and lower extremity arteries.
How is lower extremity ischemia reported in PAD studies?
Rutherford et al. (1997) in 'Recommended standards for reports dealing with lower extremity ischemia: Revised version' define categories for clinical symptoms, ankle pressure, and Doppler waveforms. These standards ensure consistent outcome reporting across PAD management trials. The classification aids comparison of revascularization results.
What is the prevalence of peripheral artery disease?
Fowkes et al. (2013) in 'Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis' report global PAD prevalence trends and risk factors from systematic data. Hirsch et al. (2001) in 'Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care' find high PAD prevalence in primary care with low physician awareness.
What antiplatelet therapy is used in PAD patients at risk of ischaemic events?
The CAPRIE trial by Dennis (1996) in 'A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)' compared clopidogrel and aspirin in reducing thrombotic events. Clopidogrel, a thienopyridine, showed benefits over aspirin in PAD patients. Both drugs reduce ischaemic risks but have adverse effects.
What techniques are used for PAD diagnosis?
Seldinger (1953) in 'Catheter Replacement of the Needle in Percutaneous Arteriography: A new technique' introduced catheter-based angiography allowing contrast injection at any vessel level with reduced extravascular risk. This method supports precise PAD lesion imaging. It remains foundational for percutaneous interventions.
How are multiple PAD treatments compared in meta-analyses?
Salanti et al. (2010) in 'Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial' describe network meta-analysis techniques for PAD therapies. These methods rank interventions using graphical and numerical summaries. They enable evidence synthesis across studies.
Open Research Questions
- ? How can physician awareness of undiagnosed PAD in primary care be improved beyond ankle-brachial index screening?
- ? What are the long-term comparative outcomes of clopidogrel versus aspirin in diverse PAD risk populations?
- ? How do global PAD prevalence trends from 2000-2010 inform current revascularization strategies?
- ? What standardized reporting gaps persist for upper extremity and renal PAD beyond lower extremity ischemia categories?
- ? How can catheter techniques evolve to minimize extravascular risks in complex atherosclerotic vessels?
Recent Trends
The 2024 AHA/ACC guideline for lower extremity PAD management was released, addressing asymptomatic, chronic symptomatic, chronic limb-threatening ischemia, and acute limb ischemia subsets.
An ACC Scientific Statement emphasizes evidence-based PAD care in diabetes patients.
Grants include Dr.
Shipra Arya's $300,000 AHA award for deep learning prognostication in PAD and Professor Ellie Tzima's Leducq Foundation funding for blood flow response mechanisms.
Research Peripheral Artery Disease Management with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Peripheral Artery Disease Management with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.